PATENT CLAIM ANALYSIS

Application Number: 16273929
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "218000"]

Abstract:
A method for treating a proliferative disease, disorder, or condition comprising administering a cis-diamine platinum(II) thione complex. A cis-diamine platinum(II) thione complex and compositions containing it.

Claim (Index 9):
The method of  claim 1 , wherein the proliferative disease, disorder or condition is cancer that is or has become resistant to cisplatin or wherein the complex produces less nephrotoxicity or neurotoxicity than the same dose of cisplatin.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 99.0
- Lexical Diversity: 1.44
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15794384', '16273986', '15715964', '15966174', '15008889']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7904358579711149
- 35 USC 102 Novelty (BERT): 0.6210379469841473
- Combined Prediction Score: 0.7734960668724182
- Mean Citation Score: 426.681578
- Max Citation Score: 572.7253400000002
- Similarity Product: 499.5763825953866

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test